Lisa Genova is an American neuroscientist and author. She self-published her debut novel Still Alice, about a Harvard University professor who suffers early onset Alzheimer’s disease.
Lisa Genova – TED Talk TRANSCRIPT
How many people here would like to live to be at least 80 years old? Yeah. I think we all have this hopeful expectation of living into old age.
Let’s project out into the future, to your future “you’s,” and let’s imagine that we’re all 85.
Now, everyone look at two people. One of you probably has Alzheimer’s disease. All right, all right. And maybe you’re thinking, “Well, it won’t be me.”
Then, OK. You are a caregiver. So — so in some way, this terrifying disease is likely to affect us all. Part of the fear around Alzheimer’s stems from the sense that there’s nothing we can do about it. Despite decades of research, we still have no disease-modifying treatment and no cure.
So if we’re lucky enough to live long enough, Alzheimer’s appears to be our brain’s destiny. But maybe it doesn’t have to be. What if I told you we could change these statistics, literally change our brain’s destiny, without relying on a cure or advancements in medicine?
Let’s begin by looking at what we currently understand about the neuroscience of Alzheimer’s. Here’s a picture of two neurons connecting. The point of connection, this space circled in red, is called the synapse.
The synapse is where neurotransmitters are released. This is where signals are transmitted, where communication happens. This is where we think, feel, see, hear, desire and remember. And the synapse is where Alzheimer’s happens.
Let’s zoom in on the synapse and look at a cartoon representation of what’s going on. During the business of communicating information, in addition to releasing neurotransmitters like glutamate into the synapse, neurons also release a small peptide called amyloid beta.
Normally, amyloid beta is cleared away metabolized by microglia, the janitor cells of our brains. While the molecular causes of Alzheimer’s are still debated, most neuroscientists believe that the disease begins when amyloid beta begins to accumulate. Too much is released, or not enough is cleared away, and the synapse begins to pile up with amyloid beta.
And when this happens, it binds to itself, forming sticky aggregates called amyloid plaques.
How many people here are 40 years old or older? You’re afraid to admit it now. This initial step into the disease, this presence of amyloid plaques accumulating, can already be found in your brains.
The only way we could be sure of this would be through a PET scan, because at this point, you are blissfully unaware. You’re not showing any impairments in memory, language, or cognition yet.
We think it takes at least 15 to 20 years of amyloid plaque accumulation before it reaches a tipping point, then triggering a molecular cascade that causes the clinical symptoms of the disease. Prior to the tipping point, your lapses in memory might include things like, “Why did I come in this room?” or “Oh what’s his name?” or “Where did I put my keys?”
Now, before you all start freaking out again, because I know half of you did at least one of those in the last 24 hours — these are all normal kinds of forgetting.
In fact, I would argue that these examples might not even involve your memory, because you didn’t pay attention to where you put your keys in the first place. After the tipping point, the glitches in memory, language and cognition are different.
Instead of eventually finding your keys in your coat pocket or on the table by the door, you find them in the refrigerator, or you find them and you think, “What are these for?”
So what happens when amyloid plaques accumulate to this tipping point? Our microglia janitor cells become hyper-activated, releasing chemicals that cause inflammation and cellular damage. We think they might actually start clearing away the synapses themselves.
A crucial neural transport protein called “tau” becomes hyperphosphorylated and twists itself into something called “tangles,” which choke off the neurons from the inside.
By mid-stage Alzheimer’s, we have massive inflammation and tangles and all-out war at the synapse and cell death. So if you were a scientist trying to cure this disease, at what point would you ideally want to intervene? Many scientists are betting big on the simplest solution: keep amyloid plaques from reaching that tipping point, which means that drug discovery is largely focused on developing a compound that will prevent, eliminate, or reduce amyloid plaque accumulation.
So the cure for Alzheimer’s will likely be a preventative medicine. We’re going to have to take this pill before we reach that tipping point, before the cascade is triggered, before we start leaving our keys in the refrigerator.
We think this is why, to date, these kinds of drugs have failed in clinical trials — not because the science wasn’t sound, but because the people in these trials were already symptomatic.
It was too late. Think of amyloid plaques as a lit match. At the tipping point, the match sets fire to the forest. Once the forest is ablaze, it doesn’t do any good to blow out the match. You have to blow out the match before the forest catches fire.